Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma

Simple Summary Oxidative stress, defined as a disturbance in the balance between the production of reactive oxygen species and antioxidant defences, is discussed in relation to its possible role in many pathological conditions, including carcinogenesis. The identification of the oxidative and nitrosative modification of proteins and the definition of their roles in clear cell renal cell carcinoma may be helpful in the elaboration of targeted therapeutic approaches to mitigate protein damage. Therefore, this study aimed to investigate the status of oxidative/nitrosative stress and to explore its role in the development and progression. Oxidative stress increased with the progression of the disease assessed according to the TNM classification and histological grade. Moreover, the presence of angioinvasion in the patients affected the level of nitrite/nitrate, lipid peroxidation and total antioxidant capacity of serum. This is the first report presenting the level of oxidative/nitrosative stress markers among clear cell renal cell carcinoma patients with and without angioinvasion. Abstract Oxidative stress is believed to be a factor in the development and progression of renal cell carcinoma (RCC). The identification of the oxidative and nitrosative modification of proteins and the definition of their roles in clear cell RCC (ccRCC) may be helpful in the elaboration of targeted therapeutic approaches to mitigate protein damage. This study aimed to investigate the status of oxidative/nitrosative stress and to explore its role in the development and progression. The studied group consisted of 48 newly diagnosed ccRCC and 30 healthy controls. Serum levels of oxidative stress markers—advanced oxidation protein products (AOPP), thiol groups, Amadori reaction products, 3-nitrotyrosine, nitrate/nitrite, malondialdehyde (MDA), 4-hydroxy-2-nonenal and total antioxidant capacity (TAC)—were determined. Additionally, associations between tumour stage assessed according to TNM classification, histological grade, and the effect of the presence of angioinvasion on the level of stress markers were evaluated. The levels of Amadori products, 3-nitrotyrosine, and nitrate/nitrite were elevated, while the levels of thiol groups and TAC decreased in the ccRCC group. The levels of AOPP, Amadori, and 3-nitrotyrosine increased, and thiol groups and TAC levels decreased with the increasing pathological stage of the tumour. In the case of advanced histological assessment of the tumour, we found decreasing levels of thiol groups and increasing levels of MDA. In patients with angioinvasion, nitrate/nitrite and MDA levels were significantly elevated compared to those in patients without angioinvasion. Oxidative stress increased with the progression of the disease assessed according to the TNM and histological grade. These results demonstrate systemic oxidative stress in ccRCC, suggesting the therapeutic application of antioxidants.

[1]  S. Galiniak,et al.  Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer , 2023, Antioxidants.

[2]  M. Tretiakova What’s new in kidney tumor pathology 2022: WHO 5th edition updates , 2022, Journal of pathology and translational medicine.

[3]  K. Izumi,et al.  Epidemiology and Prevention of Renal Cell Carcinoma , 2022, Cancers.

[4]  Zhe Zhang,et al.  Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress , 2022, Antioxidants.

[5]  A. Verim,et al.  Evaluation of advanced protein oxidation and RAGE gene variants in the risk of laryngeal cancer , 2022, Biotechnology & Biotechnological Equipment.

[6]  J. Raman,et al.  Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry , 2022, Journal of kidney cancer and VHL.

[7]  C. Costagliola,et al.  Free Radical Properties, Source and Targets, Antioxidant Consumption and Health , 2022, Oxygen.

[8]  Kwang-Won Lee,et al.  Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways. , 2021, Biological & pharmaceutical bulletin.

[9]  Guangzhen Wu,et al.  The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC , 2021, Frontiers in Oncology.

[10]  J. Kamińska,et al.  Association of Tumour Microenvironment with Protein Glycooxidation, DNA Damage, and Nitrosative Stress in Colorectal Cancer , 2021, Cancer management and research.

[11]  M. Bijak,et al.  Oxidative stress parameters as biomarkers of bladder cancer development and progression , 2021, Scientific Reports.

[12]  V. Tkachenko,et al.  Ischemia-Modified Albumin: Origins and Clinical Implications , 2021, Disease markers.

[13]  R. Nishad,et al.  Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria , 2021, Frontiers in Medicine.

[14]  N. Jha,et al.  Oxidative Stress in Cancer Cell Metabolism , 2021, Antioxidants.

[15]  S. Georgescu,et al.  Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma , 2020, Metabolites.

[16]  F. Fazio,et al.  Assessment of Total Antioxidant Capacity in Serum of Heathy and Stressed Hens , 2020, Animals : an open access journal from MDPI.

[17]  U. Testa,et al.  Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets , 2020, Medicines.

[18]  K. Tew,et al.  Oxidative Stress in Cancer. , 2020, Cancer cell.

[19]  A. Mohammed,et al.  Epidemiology of Renal Cell Carcinoma , 2020, World journal of oncology.

[20]  N. Ferrell,et al.  Glycation alters the mechanical behavior of kidney extracellular matrix , 2020, Matrix biology plus.

[21]  M. E. Norhaizan,et al.  Oxidative Stress, Diet and Prostate Cancer , 2020, The world journal of men's health.

[22]  G. Sethi,et al.  Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements , 2019, Biomolecules.

[23]  Yi Xiao,et al.  Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies , 2019, International Journal of Molecular Sciences.

[24]  S. Pejić,et al.  The effect of antioxidant status on overall survival in renal cell carcinoma , 2019, Archives of medical science : AMS.

[25]  Junhua Zheng,et al.  Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma , 2019, Journal of cancer research and therapeutics.

[26]  F. Bray,et al.  Epidemiology of Renal Cell Carcinoma. , 2019, European urology.

[27]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[28]  D. Harrison,et al.  WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies , 2018, World Journal of Urology.

[29]  M. Vincent,et al.  Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype , 2018, International journal of cancer.

[30]  A. Merseburger,et al.  Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition , 2017, Current opinion in urology.

[31]  R. Sahu,et al.  Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization , 2017, Integrative cancer therapies.

[32]  S. Sahoo,et al.  Evaluation of ischemia-modified albumin, oxidative stress, and antioxidant status in acute ischemic stroke patients , 2017, Journal of natural science, biology, and medicine.

[33]  P. S. Mahalingaiah,et al.  Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells , 2016, Oncotarget.

[34]  C. la Vecchia,et al.  The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. , 2016, European urology.

[35]  W. Rathmell,et al.  Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas , 2016, Molecular Cancer Research.

[36]  O. Erel,et al.  Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma , 2015, Central European journal of urology.

[37]  G. Kaushik,et al.  Status of oxidative stress in patients with renal cell carcinoma. , 2012, The Journal of urology.

[38]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  T. Simić,et al.  Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes. , 2008, Urologic oncology.

[40]  M. Akıncı,et al.  Advanced Oxidation Protein Products, Ferrous Oxidation in Xylenol Orange, and Malondialdehyde Levels in Thyroid Cancer , 2007, Annals of Surgical Oncology.

[41]  T. Tammela,et al.  Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[42]  M. Gago-Domínguez,et al.  Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights. , 2006, Free radical biology & medicine.

[43]  T. Tammela,et al.  Antioxidant enzymes in renal cell carcinoma. , 2006, Histology and histopathology.

[44]  I. Ivanov,et al.  Evidence for non‐enzymatic glycosylation of Escherichia coli chromosomal DNA , 2005, Molecular microbiology.

[45]  M. Denis,et al.  Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling , 2004, British Journal of Cancer.

[46]  D. Bar-Or,et al.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.

[47]  C. Rice-Evans,et al.  Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.

[48]  P. Jungers,et al.  Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure1, 2 , 1998, The Journal of Immunology.

[49]  P. Jungers,et al.  Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.

[50]  J J Strain,et al.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.

[51]  P. Metcalf,et al.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[52]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[53]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[54]  Handbook of Oxidative Stress in Cancer: Mechanistic Aspects , 2022 .

[55]  C. Pathak,et al.  Advanced Glycation End Products Mediated Oxidative Stress and Regulated Cell Death Signaling in Cancer , 2021, Handbook of Oxidative Stress in Cancer: Mechanistic Aspects.

[56]  B. Ratliff,et al.  Oxidant Mechanisms in Renal Injury and Disease. , 2016, Antioxidants & redox signaling.

[57]  Robert Li,et al.  Defining ROS in Biology and Medicine. , 2016, Reactive oxygen species.

[58]  D. Dash,et al.  Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. , 2013, Aging and disease.

[59]  B. Sancak,et al.  Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade. , 2004, Neoplasma.

[60]  K. Yagi Assay for blood plasma or serum. , 1984, Methods in enzymology.